Literature DB >> 22857012

Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.

Hang Chen1, Ying Zhang, Liang Li, Ju-Guang Han.   

Abstract

Soluble epoxide hydrolase (sEH) has become a new therapeutic target for treating a variety of human diseases. The inhibition of human sEH hydrolase activity was studied by molecular docking and molecular dynamics (MD) simulation techniques. A set of six benzoxazole-based amide inhibitors binding to sEH has been studied through molecular docking, MD simulation, free energy calculations, and energy decomposition analysis. On the basis of molecular mechanics-generalized Born/surface area (MM-GB/SA) computation and normal-mode analysis (NMA), the obtained results indicate that the rank of calculated binding free energies (ΔΔGTOT) of these inhibitors is in excellent agreement with that of experimental bioactivity data (IC50). The correlation coefficient (r(2)) between the predicted ΔΔGTOT and IC50 is 0.88. van der Waals energies are the largest component of the total energies, and the entropy changes play an indispensable role in determining the ΔΔGTOT. Rational binding modes were discussed and determined by the docking results and binding free energies. The free energy decomposition of each residue reveals that the residue Trp334 dominates the most binding free energies among all residues and that the activities for these molecules to the sEH are not decided by hydrogen bonds or a certain residue but by the common effect of multiple side chains in the active site.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22857012     DOI: 10.1021/jp304736e

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Probing the orientation of inhibitor and epoxy-eicosatrienoic acid binding in the active site of soluble epoxide hydrolase.

Authors:  Kin Sing Stephen Lee; Niel M Henriksen; Connie J Ng; Jun Yang; Weitao Jia; Christophe Morisseau; Armann Andaya; Michael K Gilson; Bruce D Hammock
Journal:  Arch Biochem Biophys       Date:  2016-10-29       Impact factor: 4.013

2.  Inhibition Mechanisms of (-)-Epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of Alzheimer's Disease via Molecular Simulations.

Authors:  Mei Fang; Quan Zhang; Xin Wang; Kehe Su; Ping Guan; Xiaoling Hu
Journal:  ACS Omega       Date:  2022-05-31

3.  Identifying simultaneous matrix metalloproteinases/soluble epoxide hydrolase inhibitors.

Authors:  Ahmed A El-Sherbeni; Rabia Bhatti; Fadumo A Isse; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2022-01-24       Impact factor: 3.396

4.  Probing the effect of the non-active-site mutation Y229W in New Delhi metallo-β-lactamase-1 by site-directed mutagenesis, kinetic studies, and molecular dynamics simulations.

Authors:  Jiao Chen; Hui Chen; Yun Shi; Feng Hu; Xingzhen Lao; Xiangdong Gao; Heng Zheng; Wenbing Yao
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

5.  Excellent Degradation Performance of a Versatile Phthalic Acid Esters-Degrading Bacterium and Catalytic Mechanism of Monoalkyl Phthalate Hydrolase.

Authors:  Shuanghu Fan; Junhuan Wang; Yanchun Yan; Jiayi Wang; Yang Jia
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

6.  Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays.

Authors:  Ling Wang; Lei Chen; Miao Yu; Li-Hui Xu; Bao Cheng; Yong-Sheng Lin; Qiong Gu; Xian-Hui He; Jun Xu
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.